Companies stare at huge losses as unsold Covid drugs pile up

During the two years of the pandemic, there were sky-rocketing sales of Covid-19 portfolio of drugs, sometimes even severe shortages. But now the industry is saddled with a huge inventory of raw materials and medicines used in Covid-19, and staring at potential losses and write-offs running into hundreds of crores. Via Times of India https://ift.tt/nu1KwVB